4 ms·
their data could be very valuable depending on the evolution of personal medicine.
by PunchTornado 7y ago
their data could be very valuable depending on the evolution of personal medicine.
- avocado4 7y agoThat was probably the justification for a high valuation. Also explains the recent pharma pivot.
- nradov 7y agoTheir existing data can't really be used for personalized medicine. If they want to pursue that market they'll need different testing protocols and additional regulatory approvals.
- PunchTornado 7y agoregulatory approval is easy to get with the right kind of lobbying. i would say assays are useful for personal medicine. they get about 6m variants.